Physician profile
David Cohen
NPI 1598762668
$9,587.56
in general payments reported to CMS, 2019-2025
47 companies · $1,662 in 2025
The $1,662 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $547 · 2021: $899 · 2022: $1,890 · 2023: $1,891 · 2024: $1,969 · 2025: $1,662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,329 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,329.19 |
| Education | $193.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,872.29 | 2019-2025 | Rinvoq, Creon, Skyrizi |
| Janssen Biotech, INC. | $1,452.75 | 2019-2025 | Tremfya, Stelara |
| Janssen Scientific Affairs, LLC | $584.09 | 2020-2025 | Tremfya |
| Lilly USA, LLC | $497.90 | 2022-2025 | Mounjaro, Omvoh, Zepbound |
| Novo Nordisk INC | $435.41 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $415.09 | 2019-2023 | Exalt Model D, Resolution 360 Clip |
| Pfizer INC. | $297.62 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $296.18 | 2022-2024 | |
| Intercept Pharmaceuticals, INC. | $290.78 | 2019-2023 | Ocaliva |
| Ardelyx, INC. | $281.93 | 2023-2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $277.51 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $235.44 | 2019-2025 | Eohilia |
| Madrigal Pharmaceuticals | $222.75 | 2024-2025 | Rezdiffra |
| Celgene Corporation | $200.51 | 2021-2023 | Zeposia |
| Biohaven Pharmaceutical Holding Company LTD. | $194.78 | 2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.